Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles.

Chorny M, Hood E, Levy RJ, Muzykantov VR.

J Control Release. 2010 Aug 17;146(1):144-51. doi: 10.1016/j.jconrel.2010.05.003. Epub 2010 May 18.

2.

Targeting of superoxide dismutase and catalase to vascular endothelium.

Muzykantov VR.

J Control Release. 2001 Mar 12;71(1):1-21. Review.

PMID:
11245904
3.

Nanocarriers for vascular delivery of antioxidants.

Hood E, Simone E, Wattamwar P, Dziubla T, Muzykantov V.

Nanomedicine (Lond). 2011 Sep;6(7):1257-72. doi: 10.2217/nnm.11.92. Review.

4.

Delivery of antioxidant enzyme proteins to the lung.

Muzykantov VR.

Antioxid Redox Signal. 2001 Feb;3(1):39-62. Review.

PMID:
11291598
5.

Antioxidant strategies in respiratory medicine.

Christofidou-Solomidou M, Muzykantov VR.

Treat Respir Med. 2006;5(1):47-78. Review.

PMID:
16409015
6.

Targeted interception of signaling reactive oxygen species in the vascular endothelium.

Han J, Shuvaev VV, Muzykantov VR.

Ther Deliv. 2012 Feb;3(2):263-76. Review.

7.

Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery.

Estelrich J, Escribano E, Queralt J, Busquets MA.

Int J Mol Sci. 2015 Apr 10;16(4):8070-101. doi: 10.3390/ijms16048070. Review.

8.

Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances.

Nash KM, Ahmed S.

Nanomedicine. 2015 Nov;11(8):2033-40. doi: 10.1016/j.nano.2015.07.003. Epub 2015 Aug 6. Review.

9.

The role of oxidative stress on carotene production by Blakeslea trispora in submerged fermentation.

Roukas T.

Crit Rev Biotechnol. 2016;36(3):424-33. doi: 10.3109/07388551.2014.989424. Epub 2015 Jan 20. Review.

PMID:
25600464
10.

Enzymatic antioxidant system in vascular inflammation and coronary artery disease.

Lubrano V, Balzan S.

World J Exp Med. 2015 Nov 20;5(4):218-24. doi: 10.5493/wjem.v5.i4.218. eCollection 2015 Nov 20. Review.

11.

Targeting antioxidant and antithrombotic biotherapeutics to endothelium.

Carnemolla R, Shuvaev VV, Muzykantov VR.

Semin Thromb Hemost. 2010 Apr;36(3):332-42. doi: 10.1055/s-0030-1253455. Epub 2010 May 20. Review.

12.

Magnetic nanoparticles for theragnostics.

Shubayev VI, Pisanic TR 2nd, Jin S.

Adv Drug Deliv Rev. 2009 Jun 21;61(6):467-77. doi: 10.1016/j.addr.2009.03.007. Epub 2009 Apr 20. Review.

13.

Targeting antioxidant enzyme expression as a therapeutic strategy for ischemic stroke.

Davis SM, Pennypacker KR.

Neurochem Int. 2017 Jul;107:23-32. doi: 10.1016/j.neuint.2016.12.007. Epub 2016 Dec 30. Review.

PMID:
28043837
14.

Targeted delivery of therapeutics to endothelium.

Simone E, Ding BS, Muzykantov V.

Cell Tissue Res. 2009 Jan;335(1):283-300. doi: 10.1007/s00441-008-0676-7. Epub 2008 Sep 25. Review.

15.

Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach.

Glorieux C, Calderon PB.

Biol Chem. 2017 Jul 28. pii: /j/bchm.ahead-of-print/hsz-2017-0131/hsz-2017-0131.xml. doi: 10.1515/hsz-2017-0131. [Epub ahead of print] Review.

PMID:
28384098
16.

Reactive-Oxygen-Species-Responsive Drug Delivery Systems: Promises and Challenges.

Saravanakumar G, Kim J, Kim WJ.

Adv Sci (Weinh). 2016 Jun 8;4(1):1600124. doi: 10.1002/advs.201600124. eCollection 2017 Jan. Review.

17.

Blood substitutes: possibilities with nanotechnology.

Alam F, Yadav N, Ahmad M, Shadan M.

Indian J Hematol Blood Transfus. 2014 Sep;30(3):155-62. doi: 10.1007/s12288-013-0309-5. Epub 2013 Dec 10. Review.

Supplemental Content

Support Center